Previous 10 | Next 10 |
New data confirms Smith+Nephew technology as the best performing cementless construct for Total Hip Arthroplasty¹ LONDON , Dec. 16, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced outstanding clinica...
Integra LifeSciences is in the late stages of a transition period, rounded off by the recent divestiture of the orthopaedics segment, to be closed next year. The company has had a strong sequential quarter, which may carry through to Q4 should the pandemic begin to settle over a resur...
Smith+Nephew announces RI.INSIGHTS - a global data analytics platform designed to advance the standard of care for robotics-assisted joint replacement procedures LONDON , Dec. 8, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business...
New data shows Smith+Nephew's NOVOSTITCH™ Meniscal Repair Systems achieve 82.6% success rate for difficult to repair¹ horizontal cleavage tears at two years follow-up Results further underscore the clinical efficacy and benefit of meniscal repair versus removal P...
Smith & Nephew has failed to make its recovery to pre-pandemic levels, although key segments are likely in a deferral rather than a long-term loss. Lack of visibility and guidance from management highlights the risks investors must factor in, and reflects the pricing activity we'v...
Smith & Nephew has a solid, growing business which will grow with market growth as well as by acquisition. It has a decent dividend payment history. Don't expect amazing performance, but on a mid- to long-term basis (3-5+ years), I expect share price appreciation will reward t...
Smith+Nephew adds patient selection and care-pathway optimization tools to ARIA Digital Care Management Platform for ASCs PR Newswire LONDON, Nov. 5, 2020 LONDON , Nov. 5, 2020 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology bus...
Smith & Nephew plc (SNN) Q3 2020 Earnings Conference Call October 29, 2020 4:30 AM ET Company Participants Roland Diggelmann – Chief Executive Officer Anne-Francoise Nesmes – Chief Financial Officer Conference Call Participants Tom Jones – Berenberg Kyle Rose –...
Image source: The Motley Fool. Smith & Nephew plc (NYSE: SNN) Q3 2020 Earnings Call Oct 29, 2020 , 4:30 a.m. ET Operator Continue reading For further details see: Smith & Nephew plc (SNN) Q3 2020 Earnings Call Transcript
Smith & Nephew (SNN): Q3 Revenue of $1.2B (-4.0% Y/Y) in-line.Press Release For further details see: Smith & Nephew revenue in-line
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...